A one-off programme designed around specific client questions. Each patient’s diagnosis, monitoring and treatment history is mapped through to current management, providing longitudinal value from the first wave.
Bespoke longitudinal tracker
A tailored programme that follows the same patients forward and refreshes the wider market view over time. Updates can be delivered monthly, quarterly, annually or at another agreed frequency.
A rapid early asset qualification programme for early pipeline teams and biotech companies. Horizon assesses product potential, sizes the patient opportunity and identifies the evidence or profile changes that would strengthen the asset.
One Market Potential Score out of 100 supports three clear actions: advance, refine or reconsider.